Next Article in Journal
Insulin-Mimic Components in Acer truncatum Leaves: Bio-Guided Isolation, Annual Variance Profiling and Regulating Pathway Investigated by Omics
Previous Article in Journal
Analysis of Boswellic Acid Contents and Related Pharmacological Activities of Frankincense-Based Remedies That Modulate Inflammation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts

Normandie University, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, F-76000 Rouen, France
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2021, 14(7), 661; https://doi.org/10.3390/ph14070661
Submission received: 22 June 2021 / Revised: 7 July 2021 / Accepted: 9 July 2021 / Published: 11 July 2021
(This article belongs to the Section Medicinal Chemistry)

Abstract

:
Transition-metal-free direct arylation of C-H or N-H bonds is one of the key emerging methodologies that is currently attracting tremendous attention. Diaryliodonium salts serve as a stepping stone on the way to alternative environmentally friendly and straightforward pathways for the construction of C-C and C-heteroatom bonds. In this review, we emphasize the recent synthetic advances of late-stage C(sp2)-N and C(sp2)-C(sp2) bond-forming reactions under metal-free conditions using diaryliodonium salts as arylating reagent and its applications to the synthesis of new arylated bioactive heterocyclic compounds.

1. Introduction

Late-stage diversification strategies that are based on heteroaromatic frameworks that contain multiple reactive sites are challenging and attractive for use in drug discovery [1,2,3]. Because small changes can have a huge impact on bioactive profile, this approach offers unique opportunities for the generation of new drug-like analogs of lead structures without extra synthetic steps or resorting to de novo synthesis [4,5,6,7,8,9,10,11,12,13,14,15,16,17]. While various reviews on C–H functionalization of heteroarenes have been already published [18,19,20,21,22], they are mainly focused on transition metal catalysis. In the quest for mild and sustainable late-stage functionalization, transition-metal-free diversification appears as a rewarding tool to build new functionalized heteroarene derivatives onto their established bioactive framework [23,24,25,26,27,28,29,30,31,32,33,34,35].
While designing new strategies that are mild, green, and metal-free and deliver valuable compounds is a challenge, metal-free diversification reactions via hypervalent iodine (III) reagents, including diaryl-λ3-iodane have garnered popularity [36,37,38]. In the last decade, recent progress in this area has been achieved including selective C-H and N-H arylations of heteroarenes using non-toxic and easy-to-handle diaryliodonium salts as aromatic electrophiles [39,40,41,42]. Most of the arylation reactions show high functional group tolerance and involve a symmetric diaryliodonium salt or a non-symmetric bearing an inert coupling auxiliary, also called a “dummy” group, such as TMB (2,4,6-trimethoxyphenyl), Mes (2,4,6-methylphenyl), TRIP (2,4,6-triisopropylphenyl) or uracil [43,44,45,46,47,48,49,50,51,52]. This review provides an overview of the recent developments and early examples of arylating heteroarenes under metal-free conditions using acyclic diaryliodonium salts as coupling partners. The selected recent examples, since 2014, show how the metal-free catalyzed C-H and N-H bond arylation has been able to positively affect the relevant synthesis of bioactive compounds. The mechanism details, usually involving radical intermediates, are given when they are discussed by the authors but are not fully covered here.

1.1. Metal-Free C-H Arylation of Heteroarenes

In 2009, Baran first described a new method for the arylation of skatole and substituted indoles using diaryliodonium salts in the presence of tert-butyltetramethylguanidine (BTMG), leading to various C-3 quaternarized indole derivatives like indolines after reduction, as medicinally relevant entities [53]. The same year, Kita and co-workers developed a metal-free cross-coupling method for electron-rich heteroarenes through in situ generation of σ-heteroaryl iodine(III) intermediates [54,55]. Following these pioneering research studies, Ackermann [56], Yu and Zhang [57], and Wang and Han [58] reported direct transition-metal-free arylations of indoles, pyrroles, and carbazoles, respectively, with diaryliodonium salts (Scheme 1). The reaction was also extended to pyrazine and pyridine, but the main drawback remains the use of a large excess of the azine and no selective aryl transfer using unsymmetrical diaryliodonium salts [57].
In 2014, Ackerman developed the striking bioorthogonal late-stage arylation of oligopeptides derived from indole-3-acetamide [59]. The reaction took place selectively at the C2 position of the indole moiety under base-free conditions and using symmetrical diaryliodonium tosylates as arylating reagents at 100 °C in DMF (Scheme 2). This late-stage diversification is a rewarding strategy for the straightforward synthesis of analogs of tryptophan-containing peptides.
In 2017, Kita research group explored the C2-phenylation of unprotected pyrrole as well as π-deficient azines using unsymmetrical diaryliodonium triflates in the presence of NaOH without external solvent (Scheme 3) [60]. The 2,4,6-trimethoxybenzene group (TMB) proved effective as a dummy group in favoring selective transfer of the less electron-rich and less encumbered aryl group to the heteroarene [44] and in increasing the yield of phenylated compound compared to the previous study reported by Yu and Zhang [57]. The metal-free C-H phenylation was successfully extended to imidazole, pyridine, and diazines. When the reaction is conducted with heteroarenes containing several C-H bonds as a potential point of arylation, a mixture of phenylated products was obtained. Finally, pyrazine was arylated in modest yields with para substituted phenyl and thiophene ligands.
The same year, Shibata reported a metal-free late-stage pentafluorosulfanyl (SF5) pyridylation of unprotected and N-methyl pyrroles using a novel designed electrophilic heteroaryliodonium triflates [61]. The reaction took place at the C2 position using SF5-pyridylmesityl-λ3-idoanes under the same reaction conditions reported by Kita (NaOH in pyrrole) giving the expected bi-heteroaryl products in yields ranging from 44% to 98% (Scheme 4). This attractive late-stage heteroarylation was applied to the synthesis of an SF5-analogue of an herbicide developed by Kumiai Chemical Ltd. and could find more applications in pharmaceutical industry.
A selective base-mediated C-H α-arylation was applied by Jiao to the synthesis of mono- and diarylBODIPYs using a range of symmetrical diaryliodonium triflates (Scheme 5) [62]. Unsymmetrical diaryliodonium salts are also viable reagents and led to the selective transfer of the sterically less hindered or electron-poor aromatic moiety, in contradiction with the previously reported ortho-effect [63]. Owing to DFT calculations and further experiments using a radical inhibitor, the authors suggested a radical reaction pathway (Scheme 6). In addition, the calculated free energy of plausible transition states and intermediates is in agreement with the observed selectivity. The investigation of the photophysical properties showed that they are dependent on the electronic proprieties of the aryl group(s). Strong absorption and fluorescence emission were observed for the range of mono and diarylated BODIPY dyes.
In 2018, Adimurthy described the first metal-free C3-H arylation of imidazo[1,2-a]pyridines and imidazothiazoles using symmetrical diaryliodonium salts [64]. Eco-friendly late-stage C-H functionalization of these N-bearing polycyclic scaffolds has emerged as a powerful strategy for the synthesis of libraries of highly valuable compounds. Indeed, 3-substituted imidazo[1,2-a]pyridines are attractive compounds in drug development exhibiting various pharmacological activities as well as in optoelectronic devices [65,66,67]. The direct C3-arylations were performed in the presence of tBuOK (2.0 equiv) as a base in acetonitrile at 60 °C for 24 h (Scheme 7). The pivotal role of the counter anions of the diphenyliodonium was highlighted by the higher efficiency of the chloride compared to nitrate, hexafluorophosphate, or tetrafluoroborate and confirms their huge influence on reactivity [68].
This synthetic method was successfully extended to 2-arylbenzo[d]imidazo[2,1-b]thiazoles, and the expected diarylated compounds were isolated in a 51–70% range yield (Scheme 8). The authors suggested an aryl radical intermediate based on further control experiments but without ruling out an ionic pathway involving an aryne intermediate [69].
Because of their biological activities and chemical properties, quinoxalin-2(1H)-one derivatives are considered privileged scaffolds in medicinal chemistry and in materials science [70,71]. In this context, a straightforward synthesis of 3-arylquinoxalin-2(1H)-ones is still attractive for medicinal chemists. In 2017, Zhang developed an elegant transition-metal-free C3-H arylation of quinoxalin-2(1H)-one using symmetrical diaryliodonium tetrafluoroborates in the presence of cesium carbonate at room temperature (Scheme 9) [72]. Based on further experiments with a radical scavenger, the authors suggested a radical mechanism as usually reported in metal-free arylation involving high-valence iodonium salts (Scheme 10). Compared to the former reported C-H arylation of quinoxalin-2(1H)-ones requiring high temperature, strongly acidic conditions and/or transition metal catalysts, this strategy had several evident advantages.
Very recently, the first visible light-mediated arylation of pyridine and quinoline N-oxides using eosin Y as a photocatalyst was described by Song [73] with symmetrical diaryliodonium tetrafluoroborate as coupling reagent (Scheme 11 and Scheme 12). Support for the feasibility of this photoredox catalysis with heteroarenes is provided by recent reports [74,75,76]. Compared to the previously reported strategies of direct selective arylation of quinolone and pyridine N-oxides, this protocol is of benefit, requiring no transition-metal catalyst or no sensitive organometallic reagents.
The undertaken optimization experiments proved that the presence of 1,4-benzoquinone (BQ) as additive as well as the loadings of the diphenyliodonium salt and the photocatalyst influence the efficiency of the reaction using quinoline N-oxide as substrate. The reactions were performed at room temperature for 3 days under visible-light irradiation provided by a 5 W blue LED light in the presence of Cs2CO3 as a base and eosin Y to generate aryl radicals from diaryliodonium salts by a single-electron-transfer oxidizing strategy (Scheme 13). The arylation was found to be tolerant of various substituted substrates in moderate to good yields depending on the heteroarene. This late-stage C-2 arylation of these essential pharmacophores provided a practical strategy for the synthesis of attractive N-heterobiaryl derivatives that are widely found in pharmaceuticals and natural compounds, particularly in alkaloids [77,78,79,80,81].

1.2. Metal-Free N-H Arylation of Heteroarenes

The regioselective metal-free N-arylation of heteroarenes using diaryliodonium salts opens new possibilities to access valuable target compounds in an eco-friendlier and cheaper process [82,83]. In addition, the N-arylated azoles have received considerable attention as key structural motifs of various bioactive molecules [84]. In 2012, Wang and Han reported the first transition-metal-free N-arylation of carbazoles promoted by diaryliodonium triflates in the presence of KOtBu as base under mild conditions [58]. Few years later, notwithstanding the importance of polyaryl-substituted pyrazoles [85], Novák reported a rapid metal-free N-arylation of pyrazole derivatives [86]. The reactions were carried out at room temperature for 20 min or 6 h in the presence of an aqueous solution of ammonia (25 w/w%) as a base (Scheme 14). The chemoselectivity studies conducted with various unsymmetrical diaryliodonium salts bearing diverse “dummy group” highlighted “the steric effect” that favored transfer of the more hindered group but also the more electron-deficient group. Heteroaryl groups were also readily introduced on pyrazole core leading to valuable biheteroaryl scaffolds (Scheme 15). An example of an intramolecular transfer of the mesityl group was also realized starting from the corresponding pyrazolyl(Mes)iodoium triflate under the optimized conditions.
The same group explored the mechanistic aspects of the metal-free N-arylation in aqueous media involving unsymmetrical diaryliodonium salts and pointed out the pivotal neighboring nitrogen effect [87]. The presence of a Lewis basic heteroatom in close vicinity to the Bronsted acid center allows the formation of a T-shape adduct through the association of the aryliodonium to the nitrogen (proximity effect). The vicinal nitrogen center brings the aryl ligand close to the N−H bond to form a favorable four-membered cyclic transition state. The optimal mechanism was predicted thanks to the comparison of the free energy profiles and is related to experimental chemoselectivity studies. Indeed, the authors conclude that the selectivity is kinetically controlled. Given a better understanding of the neighboring heteroatom effect, this computational study allowed the scope of the N-heteroarene to be extended to various fused-heterocycles possessing two vicinal N-sites without tautomerism (Scheme 16 and Scheme 17).
In 2018, progress in the N-arylation of pyrazoles has also been recently achieved by Cheng and co-workers, who reported a powerful and challenging iodoarylation using the in situ generation of the corresponding heteroaryl iodonium tosylate as the stepping stone of the tandem strategy [37,88]. This metal-free, one-pot difunctionalization led to the synthesis of highly valuable 1,4-disubstitued pyrazoles. The key intermediate N-H-pyrazole-iodonium salts were generated by the reaction of pyrazole derivatives with aryliodine diacetates in the presence of TsOH·H2O and the sequential 1,10-phenanthroline (1,10-phen)/K2CO3-mediated arylation furnished the desired high functionalized pyrazoles (Scheme 18).
Late-stage N-H arylation of indolines was then investigated by Natchsheim to design a streamlined and rapid synthetic route to the corresponding N-substituted compounds as key structures in organic electronics [89,90]. The reaction was extended to benzotriazole using tBuOK as a base, and the selective N2-arylation was observed in moderate yield using diaryliodonium triflates in propionitrile at 90 °C (Scheme 19). One example of phenylation of indazole was also reported in low yield.
A noteworthy strategy for the synthesis of valuable N-arylated quinolinones was recently accomplished by Kumar and co-workers using symmetrical diaryliodonium triflates or unsymmetrical salts bearing a mesityl as a “dummy” group [91]. N-arylquinolones represent a family of prominent structural motifs that are explored for their biological potential as antibacterials, antiulcers, and antitumors [92]. The appropriate quinolin-4(1H)-one or 4-methylquinolin-2(1H)-one and the diaryliodonium salt were heated in water under microwave irradiation at 80 °C for 30 min in the presence of NaOH (3.0 equiv) as a base (Scheme 20). Compared to the previously described strategy, no copper salt was needed under these mild conditions. Reaction with unsubstituted quinolin-4(1H)-one at C2 led selectively to the N-arylated compounds, whereas the O-arylation was obtained exclusively using the cumbersome 2-methyl and 2-phenyl derivatives, highlighting the predominant steric effect.
Under these optimal conditions, the scope of the heteroarene was successfully extended to acridin-9(10H)-one, 3-methylquinoxalin-2(1H)-one, and 1H-benzo[d]imidazole-2(3H)-one to give the corresponding N-phenyl compounds (Scheme 21).
In 2018, driven by the design of a metal-free strategy for the O-arylation of 2-pyridinones, Mo and co-workers observed the competitive N-arylation reaction under basic conditions (tBuOK, KOH, or Cs2CO3 as the base) [93]. The reaction of substituted 2-pyridinones with diaryliodonium triflates in the presence of Cs2CO3 (1.5 equiv) in 1,2-dichloroethane (DCE) at 120 °C led to a mixture in which the N-arylated product was obtained in most cases as the major compound depending on the substituents on the pyridinone and the steric hindrance (Scheme 22). Various functional groups such as halides, nitro, nitrile, and ester were found to be tolerant to the reaction conditions, and some drugs or precursor of bioactive compounds with a pyridinone core were easily synthesized. Although the N-arylation of pyridinones was already described using copper catalysis, this approach provides an eco-friendlier complementary approach.
Two years later, Kuriyama and Onomura disclosed a novel protocol for the selective N-arylation of various 2-pyridinones with diaryliodonium triflates or tetrafluoroborates (Scheme 23) [94]. This metal-free catalyzed N-arylation was achieved in the presence of N,N-diethylaniline as the base. The best reactivity and selectivity were observed in fluorobenzene as the solvent. This combination provides the N-arylated products in good yields ranging from 33% to 94% with high selectivities (>20:1). A control experiment with the 4-pyridinone furnished the expected N-phenylated compound with only 65% yield but with high selectivity. Both electron-donating and -withdrawing substituents on the pyridinone and diaryliodonium salts are well tolerated and led to the selective N-arylated compounds. Interestingly, the phenylation reaction was easily scaled up from 0.5 to 10 mmol without a decrease in yield. Further experiments on transfer selectivity were investigated using unsymmetrical diaryliodonium triflates. Whereas no electronic effect was observed, an anti-ortho effect was highlighted with diaryliodoniums with steric effect. In addition, mechanism investigations with radical scavengers suggested a mechanism not related to a single electron-transfer process. Based on Olofsson’s study on the metal-free N-arylation of amides, the authors proposed two pathways such as [1,2]-rearrangement as a normal ligand coupling and [2,3]-rearrangement from two possible T-shaped intermediates in equilibrium [95].
Progress in this area has been also recently achieved by Han and Wang [96], who described the selective metal-free N-arylation of 2-pyridazinone derivatives with various diaryliodonium hexafluorophosphates and its successful application to the eco-friendlier synthesis of a drug for treatment of neuropathic pain. Interestingly, the reaction proceeded in complete selectivity under base-free condition in 1,2-dichloroethane (DCE) at 100 °C for 24 h and is tolerant to various functional groups (Scheme 24). The corresponding N-arylpyridazinones were isolated in yields ranging from 40 to 80%, and the thienyl moiety was also readily introduced at 72% yield. Based on further experiments with radical scavengers such as TEMPO and BHT (2,6-di-tert-butyl-para-cresol), the authors suggested that an aryl radical intermediate is involved in the mechanism.

2. Conclusions

Late-stage metal-free bond arylation of complex heterocycles has emerged as a sustainable and powerful tool for the synthesis of building blocks for pharmaceutical chemistry and material science. This review article summarizes the recent progress reported during the past seven years in this area using symmetrical and unsymmetrical diaryliodonium salts. Several five-membered and six-membered heteroarenes were N-arylated or C-arylated under various mild reaction conditions, including base-free or room temperature, sometimes in aqueous media. Due to their significant biological importance, the development of eco-friendlier methodologies for the synthesis of new arylated heterocycles is still of interest for the chemists’ community. With the enhancement of innovative reaction conditions, powerful late-stage diversification of valuable heteroarenes will provide an opportunity to easily access bioactive analogs to facilitate drug discovery aimed at solving existing biological problems. For example, visible-light promoted arylation reaction and photoredox catalysis open the way to the innovative and attractive synthesis of high valuable heteroarenes under mild conditions.

Author Contributions

Writing—original draft preparation, C.F.; writing—review and editing, C.F. helped by T.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Acknowledgments

T.B. and C.F. thank the LABEX SynOrg (ANR-11-LABX-0029) and the “Université de Rouen-Normandie” (UNIROUEN) for their support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Fisher, B.F.; Snodgrass, H.M.; Jones, K.A.; Andorfer, M.C.; Lewis, J.C. Site-Selective C–H Halogenation Using Flavin-Dependent Halogenases Identified via Family-Wide Activity Profiling. ACS Cent. Sci. 2019, 5, 1844–1856. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Struble, T.J.; Coley, C.W.; Jensen, K.F. Multitask prediction of site selectivity in aromatic C–H functionalization reactions. React. Chem. Eng. 2020, 5, 896–902. [Google Scholar] [CrossRef] [Green Version]
  3. Cardoza, S.; Shrivash, M.K.; Das, P.; Tandon, V. Strategic Advances in Sequential C-Arylations of Heteroarenes. J. Org. Chem. 2021, 86, 1330–1356. [Google Scholar] [CrossRef] [PubMed]
  4. Wencel-Delord, J.; Glorius, F. C-H bond activation enables the rapid construction and late-stage diversification of functional molecules. Nat. Chem. 2013, 5, 369–375. [Google Scholar] [CrossRef]
  5. Cernak, T.; Dykstra, K.D.; Tyagarajan, S.; Vachal, P.; Krska, S.W. The medicinal chemist’s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 2016, 45, 546–576. [Google Scholar] [CrossRef]
  6. Durak, L.J.; Payne, J.T.; Lewis, J.C. Late-Stage Diversification of Biologically Active Molecules via Chemoenzymatic C–H Functionalization. ACS Catal. 2016, 6, 1451–1454. [Google Scholar] [CrossRef] [Green Version]
  7. Yao, H.; Liu, Y.; Tyagarajan, S.; Streckfuss, E.; Reibarkh, M.; Chen, K.; Zamora, I.; Fontaine, F.; Goracci, L.; Helmy, R.; et al. Enabling Efficient Late-Stage Functionalization of Drug-Like Molecules with LC-MS and Reaction-Driven Data Processing. Eur. J. Org. Chem. 2017, 2017, 7122–7126. [Google Scholar] [CrossRef]
  8. Shugrue, C.R.; Miller, S.J. Applications of Non enzymatic Catalysts to the Alteration of Natural Products. Chem. Rev. 2017, 117, 11894–11951. [Google Scholar] [CrossRef]
  9. Kuttruff, C.A.; Haile, M.; Kraml, J.; Tautermann, C.S. Late-Stage Functionalization of Drug-Like Molecules Using Diversinates. ChemMedChem 2018, 13, 983–987. [Google Scholar] [CrossRef]
  10. Blakemore, D.C.; Castro, L.; Churcher, I.; Rees, D.C.; Thomas, A.W.; Wilson, D.M.; Wood, A. Organic synthesis provides opportunities to transform drug discovery. Nat. Chem. 2018, 10, 383–394. [Google Scholar] [CrossRef]
  11. Boström, J.; Brown, D.G.; Young, R.J.; Keserü, G.M. Expanding the medicinal chemistry synthetic toolbox. Nat. Rev. Drug Discov. 2018, 17, 709–727. [Google Scholar] [CrossRef] [PubMed]
  12. Wang, W.; Lorion, M.M.; Shah, J.; Kapdi, A.R.; Ackermann, L. Late-Stage Peptide Diversification by Position-Selective C−H Activation. Angew. Chem. Int. Ed. 2018, 57, 14700–14717. [Google Scholar] [CrossRef] [PubMed]
  13. Moir, M.; Danon, J.J.; Reekie, T.A.; Kassiou, M. An overview of late-stage functionalization in today’s drug discovery. Expert Opin. Drug Discov. 2019, 14, 1137–1149. [Google Scholar] [CrossRef] [PubMed]
  14. Fessner, N.D. P450 Monooxygenases Enable Rapid Late-Stage Diversification of Natural Products via C-H Bond Activation. ChemCatChem 2019, 11, 2226–2242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Capaldo, L.; Lafayette Quadri, L.; Ravelli, D. Photocatalytic hydrogen atom transfer: The philosopher’s stone for late-stage functionalization? Green Chem. 2020, 22, 3376–3396. [Google Scholar] [CrossRef]
  16. Hong, B.; Luo, T.; Lei, X. Late-Stage Diversification of Natural Products. ACS Cent. Sci. 2020, 6, 622–635. [Google Scholar] [CrossRef] [Green Version]
  17. Cannalire, R.; Pelliccia, S.; Sancineto, L.; Novellino, E.; Tron, G.C.; Giustiniano, M. Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds. Chem. Soc. Rev. 2021, 50, 766–897. [Google Scholar] [CrossRef]
  18. Yang, Y.; Lan, J.; You, J. Oxidative C–H/C–H Coupling Reactions between Two (Hetero)arenes. Chem. Rev. 2017, 117, 8787–8863. [Google Scholar] [CrossRef]
  19. Murakami, K.; Yamada, S.; Kaneda, T.; Itami, K. C–H Functionalization of Azines. Chem. Rev. 2017, 117, 9302–9332. [Google Scholar] [CrossRef]
  20. Kaur, M.; Van Humbeck, J.F. Recent trends in catalytic sp3 C–H functionalization of heterocycles. Org. Biomol. Chem. 2020, 18, 606–617. [Google Scholar] [CrossRef] [Green Version]
  21. Huang, H.-Y.; Benzai, A.; Shi, X.; Doucet, H. Effective Tools for the Metal-Catalyzed Regiodivergent Direct Arylations of (Hetero)arenes. Chem. Rec. 2021, 21, 343–356. [Google Scholar] [CrossRef]
  22. Basak, S.; Dutta, S.; Maiti, D. Accessing C2-Functionalized 1,3-(Benz)azoles through Transition Metal-Catalyzed C−H Activation. Chem. Eur. J. 2021, 27, 475. [Google Scholar] [CrossRef]
  23. Mehta, V.V.; Punji, B. Recent advances in transition-metal-free direct C–C and C–heteroatom bond forming reactions. RSC Adv. 2013, 3, 11957–11986. [Google Scholar] [CrossRef]
  24. Samanta, R.; Matcha, K.; Antonchick, A.P. Metal-Free Oxidative Carbon-Heteroatom Bond Formation Through C–H Bond Functionalization. Eur. J. Org. Chem. 2013, 2013, 5769–5804. [Google Scholar] [CrossRef]
  25. Sun, C.-L.; Shi, Z.-J. Transition-Metal-Free Coupling Reactions. Chem. Rev. 2014, 114, 9219–9280. [Google Scholar] [CrossRef]
  26. Rossi, R.; Lessi, M.; Manzini, C.; Marianetti, G.; Bellina, F. Transition Metal-Free Direct C-H (Hetero)arylation of Heteroarenes: A Sustainable Methodology to Access (Hetero)aryl-Substituted Heteroarenes. Adv. Synth. Catal. 2015, 357, 3777–3814. [Google Scholar] [CrossRef]
  27. Roopan, S.M.; Palaniraja, J. Synthetic journey towards transition metal-free arylations. Res. Chem. Intermed. 2015, 41, 8111–8146. [Google Scholar] [CrossRef]
  28. Narayan, R.; Matcha, K.; Antonchick, A.P. Metal-Free Oxidative C-C Bond Formation through C-H Bond Functionalization. Chem. Eur. J. 2015, 21, 14678–14693. [Google Scholar] [CrossRef] [PubMed]
  29. Bose, S.K.; Marder, T.B. A leap ahead for activating C-H bonds. Science 2015, 349, 473–474. [Google Scholar] [CrossRef]
  30. Légaré, J.L.; Courtemanche, M.-A.; Rochette, E.; Fontaine, F.-G. Metal-free catalytic C-H bond activation and borylation of heteroarenes. Science 2015, 349, 513–516. [Google Scholar] [CrossRef] [Green Version]
  31. Toutov, A.A.; Liu, W.-B.; Betz, K.N.; Fedorov, A.; Stoltz, B.M.; Grubbs, R.H. Silylation of C–H bonds in aromatic heterocycles by an Earth-abundant metal catalyst. Nature 2015, 518, 80–84. [Google Scholar] [CrossRef] [Green Version]
  32. Légaré Lavergne, J.L.; Jayaraman, A.; Castro, L.C.M.; Rochette, E.; Fontaine, F.-G. Metal-Free Borylation of Heteroarenes Using Ambiphilic Aminoboranes: On the Importance of Sterics in Frustrated Lewis Pair C–H Bond Activation. J. Am. Chem. Soc. 2017, 139, 14714–14723. [Google Scholar] [CrossRef] [Green Version]
  33. Lv, J.; Chen, X.; Xue, X.-S.; Zhao, B.; Liang, Y.; Wang, M.; Jin, L.; Yuan, Y.; Han, Y.; Zhao, Y.; et al. Metal-free directed sp2-C–H borylation. Nature 2019, 575, 336–340. [Google Scholar] [CrossRef] [PubMed]
  34. Luo, T.; Tian, S.; Wan, J.-P.; Liu, Y. Recent Advances in Transition Metal-Free Halogenation of C(sp2)-H Bonds. Curr. Org. Chem. 2021, 25, 1180–1193. [Google Scholar] [CrossRef]
  35. Wang, Z.-J.; Chen, X.; Wu, L.; Wong, J.J.; Liang, Y.; Zhao, Y.; Houk, K.N.; Shi, Z. Metal-Free Directed C−H Borylation of Pyrroles. Angew. Chem. Int. Ed. 2021, 60, 8500–8504. [Google Scholar] [CrossRef] [PubMed]
  36. Budhwan, R.; Yadava, S.; Murarka, S. Late stage functionalization of heterocycles using hypervalent iodine(III) reagents. Org. Biomol. Chem. 2019, 17, 6326–6341. [Google Scholar] [CrossRef]
  37. Kandimalla, S.R.; Parvathaneni, S.P.; Sabitha, G.; Reddy, B.V.S. Recent Advances in Intramolecular Metal-Free Oxidative C–H Bond Aminations Using Hypervalent Iodine(III) Reagents. Eur. J. Org. Chem. 2019, 1687–1714. [Google Scholar] [CrossRef]
  38. Mudithanapelli, C.; Kim, M. Metal-free late-stage C(sp2)–H functionalization of N-aryl amines with various sodium salts. Org. Biomol. Chem. 2020, 18, 450–464. [Google Scholar] [CrossRef]
  39. Merritt, E.A.; Olofsson, B. Diaryliodonium Salts: A Journey from Obscurity to Fame. Angew. Chem. Int. Ed. 2009, 48, 9052–9070. [Google Scholar] [CrossRef]
  40. Olofsson, B. Arylation with Diaryliodonium Salts. In Hypervalent Iodine Chemistry. Topics in Current Chemistry; Wirth, T., Ed.; Springer: Cham, Switzerland, 2015; Volume 373. [Google Scholar] [CrossRef]
  41. Aradi, K.; Tóth, B.L.; Tolnai, G.L.; Novák, Z. Diaryliodonium Salts in Organic Syntheses: A Useful Compound Class for Novel Arylation Strategies. Synlett 2016, 27, 1456–1485. [Google Scholar] [CrossRef]
  42. Pacheco-Benichou, A.; Besson, T.; Fruit, C. Diaryliodoniums Salts as Coupling Partners for Transition-Metal Catalyzed C- and N-Arylation of Heteroarenes. Catalysts 2020, 10, 483. [Google Scholar] [CrossRef]
  43. Seidl, T.L.; Sundalam, S.K.; McCullough, B.; Stuart, D.R. Unsymmetrical Aryl(2,4,6-trimethoxyphenyl)iodonium Salts: One-Pot Synthesis, Scope, Stability, and Synthetic Studies. J. Org. Chem. 2016, 81, 1998–2009. [Google Scholar] [CrossRef] [PubMed]
  44. Stuart, D.R. Aryl Transfer Selectivity in Metal-Free Reactions of Unsymmetrical Diaryliodonium Salts. Chem. Eur. J. 2017, 23, 15852–15863. [Google Scholar] [CrossRef]
  45. Carreras, V.; Sandtorv, A.H.; Stuart, D.R. Synthesis of Aryl(2,4,6-trimethoxyphenyl)iodonium Trifluoroacetate Salts. J. Org. Chem. 2017, 82, 1279–1284. [Google Scholar] [CrossRef] [PubMed]
  46. Lindstedt, E.; Reitti, M.; Olofsson, B. One-Pot Synthesis of Unsymmetric Diaryliodonium Salts from Iodine and Arenes. J. Org. Chem. 2017, 82, 11909–11914. [Google Scholar] [CrossRef]
  47. Seidl, T.L.; Moment, A.; Orella, C.; Vickery, T.; Stuart, D.R. Synthesis of 4-Methylbenzoate(2′,4′,6′-trimethoxyphenyl)iodonium Tosylate. Org. Synth. 2019, 96, 137–149. [Google Scholar] [CrossRef]
  48. Dohi, T.; Hayashi, T.; Ueda, S.; Shoji, T.; Komiyama, K.; Takeuchi, H.; Kita, Y. Recyclable synthesis of mesityl iodonium(III) salts. Tetrahedron 2019, 75, 3617–3627. [Google Scholar] [CrossRef]
  49. Tóth, B.L.; Béke, F.; Egyed, O.; Bényei, A.; Stirling, A.; Novák, Z. Synthesis of Multifunctional Aryl(trifloxyalkenyl)iodonium Triflate Salts. ACS Omega 2019, 4, 9188–9197. [Google Scholar] [CrossRef] [Green Version]
  50. Gallagher, R.T.; Basu, S.; Stuart, D.R. Trimethoxyphenyl (TMP) as a Useful Auxiliary for in situ Formation and Reaction of Aryl(TMP)iodonium Salts: Synthesis of Diaryl Ethers. Adv. Synth. Catal. 2020, 362, 320–325. [Google Scholar] [CrossRef] [Green Version]
  51. Komiyama, K.; Kobayashi, S.; Shoji, T.; Kikushima, K.; Dohi, T.; Kita, Y. Practical synthesis of diaryliodonium(iii) triflates using ArI(OAc)2/TfOH/MeCN reaction system. Russ. Chem. Bull. 2020, 69, 2328–2332. [Google Scholar] [CrossRef]
  52. Takenaga, N.; Kumar, R.; Dohi, T. Heteroaryliodonium(III) Salts as Highly Reactive Electrophiles. Front. Chem. 2020, 8, 599026. [Google Scholar] [CrossRef]
  53. Eastman, K.; Baran, P.S. A simple method for the direct arylation of indoles. Tetrahedron 2009, 65, 3149–3154. [Google Scholar] [CrossRef]
  54. Kita, Y.; Morimoto, K.; Ito, M.; Ogawa, C.; Goto, A.; Dohi, T. Metal-Free Oxidative Cross-Coupling of Unfunctionalized Aromatic Compounds. J. Am. Chem. Soc. 2009, 131, 1668–1669. [Google Scholar] [CrossRef] [PubMed]
  55. Morimoto, K.; Yamaoka, N.; Ogawa, C.; Nakae, T.; Fujioka, H.; Dohi, T.; Kita, Y. Metal-Free Regioselective Oxidative Biaryl Coupling Leading to Head-to-Tail Bithiophenes: Reactivity Switching, a Concept Based on the Iodonium(III) Intermediate. Org. Lett. 2010, 12, 3804–3807. [Google Scholar] [CrossRef]
  56. Ackermann, L.; Dell’Acqua, M.; Fenner, S.; Vicente, R.; Sandmann, R. Metal-Free Direct Arylations of Indoles and Pyrroles with Diaryliodonium Salts. Org. Lett. 2011, 13, 2358–2360. [Google Scholar] [CrossRef] [PubMed]
  57. Wen, J.; Zhang, R.-Y.; Chen, S.-Y.; Zhang, J.; Yu, X.-Q. Direct Arylation of Arene and N-Heteroarenes with Diaryliodonium Salts without the Use of Transition Metal Catalyst. J. Org. Chem. 2012, 77, 766–771. [Google Scholar] [CrossRef]
  58. Guo, F.; Wang, L.; Wang, P.; Yu, J.; Han, J. Transition-Metal-Free N-Arylation of Carbazoles and C-Arylation of Tetrahydrocarbazoles by using Diaryliodonium Salts. Asian J. Org. Chem. 2012, 1, 218–221. [Google Scholar] [CrossRef]
  59. Zhu, Y.; Bauer, M.; Ploog, J.; Ackermann, L. Late-Stage Diversification of Peptides by Metal-Free C-H Arylation. Chem. Eur. J. 2014, 20, 13099–13102. [Google Scholar] [CrossRef] [PubMed]
  60. Dohi, T.; Ueda, S.; Hirai, A.; Kojima, Y.; Morimoto, K.; Kita, Y. Selective Aryl Radical Transfers into N-Heteroaromatics from Diaryliodonoium Salts with Trimethoxybenzene Auxiliary. Heterocycles 2017, 95, 1272–1284. [Google Scholar] [CrossRef]
  61. Das, P.; Takada, M.; Matsuzaki, K.; Saito, N.; Shibata, N. SF5-pyridylaryl-λ3-iodonium salts and their utility as electrophilic reagents to access SF5 pyridine derivatives in the late-stage of synthesis. Chem. Commun. 2017, 53, 3850–3853. [Google Scholar] [CrossRef] [PubMed]
  62. Zhou, X.; Wu, Q.; Yu, Y.; Yu, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Metal-Free Direct α-Selective Arylation of Boron Dipyrromethenes via Base-Mediated C−H Functionalization. Org. Lett. 2016, 18, 736–739. [Google Scholar] [CrossRef] [PubMed]
  63. Malmgren, J.; Santoro, S.; Jalalian, N.; Himo, F.; Olofsson, B. Arylation with unsymmetrical diaryliodonium salts: A chemoselectivity study. Chemistry 2013, 19, 10334–10342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Kumar, R.; Ravi, C.; Rawat, D.; Adimurth, S. Base-Promoted Transition-Metal-Free Arylation of Imidazo-Fused Heterocycles with Diaryliodonium Salts. Eur. J. Org. Chem. 2018, 2018, 1665–1673. [Google Scholar] [CrossRef]
  65. Tashrifi, Z.; Mohammadi-Khanaposhtani, M.; Larijani, B.; Mahdavi, M. C3-Functionalization of Imidazo[1,2-a]pyridines. Eur. J. Org. Chem. 2020, 269–284. [Google Scholar] [CrossRef]
  66. Gundlewad, G.B.; Wagh, S.S.; Patil, B.R. Catalyst and Solvent Free Synthesis and Biological Activities of Imidazo[1,2-a]pyridine. Asian J. Org. Med. Chem. 2020, 5, 221–226. [Google Scholar] [CrossRef]
  67. Mohana Roopan, S.; Patil, S.M.; Palaniraja, J. Recent synthetic scenario on imidazo[1,2-a]pyridines chemical intermediate. Res. Chem. Intermed. 2016, 42, 2749–2790. [Google Scholar] [CrossRef]
  68. Seidl, T.L.; Stuart, D.R. An Admix Approach to Determine Counter Anion Effects on Metal-Free Arylation Reactions with Diaryliodonium Salts. J. Org. Chem. 2017, 82, 11765–11771. [Google Scholar] [CrossRef] [PubMed]
  69. Patel, O.P.S.; Nandwana, N.K.; Legoabe, L.J.; Das, B.C.; Kumar, A. Recent Advances in Radical C−H Bond Functionalization of Imidazoheterocycles. Adv. Synth. Catal. 2020, 362, 4226–4255. [Google Scholar] [CrossRef]
  70. Ke, Q.; Yan, G.; Yu, J.; Wu, X. Recent advances in the direct functionalization of quinoxalin-2(1H)-ones. Org. Biomol. Chem. 2019, 17, 5863–5881. [Google Scholar] [CrossRef] [PubMed]
  71. Tan, Y.; Wang, J.; Zhang, H.-Y.; Zhang, Y.; Zhao, J. The C3-H Bond Functionalization of Quinoxalin-2(1H)-Ones With Hypervalent Iodine(III) Reagents. Front. Chem. 2020, 8, 582. [Google Scholar] [CrossRef]
  72. Yin, K.; Zhang, R. Transition-Metal-Free Direct C–H Arylation of Quinoxalin-2(1H)-ones with Diaryliodonium Salts at Room Temperature. Org. Lett. 2017, 19, 1530–1533. [Google Scholar] [CrossRef]
  73. Li, D.; Liang, C.; Jiang, Z.; Zhang, J.; Zhuo, W.-T.; Zou, F.-Y.; Wang, W.-P.; Gao, G.-L.; Song, J. Visible-Light-Promoted C2 Selective Arylation of Quinoline and Pyridine N Oxides with Diaryliodonium Tetrafluoroborate. J. Org. Chem. 2020, 85, 2733–2742. [Google Scholar] [CrossRef]
  74. Hari, D.P.; Hering, T.; Koenig, B. Chapter 8: Arene functionalization by visible light photoredox catalysis. In Visible Light Photocatalysis in Organic Chemistry; Yoon, T.P., Stephenson, C.R.J., MacMillan, D.W.C., Eds.; Whiley-VCH Verlag GmbH & Co. KGaA: Wheinheim, Germany, 2018; pp. 253–281. [Google Scholar] [CrossRef]
  75. Dixneuf, P.H.; Soulé, J.F. Functionalization of C(sp2)–H bonds of arenes and heteroarenes assisted by photoredox catalysts for the C–C Bond Formation. In Organometallics for Green Catalysis. Topics in Organometallic Chemistry; Dixneuf, P., Soulé, J.F., Eds.; Springer: Cham, Switzerland, 2018; Volume 63, pp. 225–265. [Google Scholar] [CrossRef]
  76. Chen, C.; Wang, X.; Yang, T. Recent Synthetic Applications of the Hypervalent Iodine(III) Reagents in Visible-Light-Induced Photoredox Catalysis. Front. Chem. 2020, 8, 849–870. [Google Scholar] [CrossRef]
  77. Wang, D.; Désaubry, L.; Li, G.; Huang, M.; Zheng, S. Recent Advances in the Synthesis of C2-Functionalized Pyridines and Quinolines Using N-Oxide Chemistry. Adv. Synth. Catal. 2021, 363, 2–39. [Google Scholar] [CrossRef]
  78. Afzal, O.; Kumar, S.; Haider, M.R.; Ali, M.R.; Kumar, R.; Jaggi, M.; Bawa, S. A review on anticancer potential of bioactive heterocycle quinoline. Eur. J. Med. Chem. 2015, 97, 871–910. [Google Scholar] [CrossRef] [PubMed]
  79. Dorababu, A. Report on Recently (2017–20) Designed Quinoline-Based Human Cancer Cell Growth Inhibitors. ChemistrySelect 2020, 5, 13902–13915. [Google Scholar] [CrossRef]
  80. Matada, B.S.; Pattanashettar, R.; Yernale, N.G. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg. Med. Chem. 2021, 32, 115973. [Google Scholar] [CrossRef] [PubMed]
  81. Weyesa, A.; Mulugeta, E. Recent advances in the synthesis of biologically and pharmaceutically active quinoline and its analogues: A review. RSC Adv. 2021, 10, 20784–20793. [Google Scholar] [CrossRef]
  82. Chen, J.-Y.; Wu, W.; Li, Q.; Wei, W.-T. Visible-Light Induced C(sp3)−H Functionalization for the Formation of C−N Bonds under Metal Catalyst-Free Conditions. Adv. Synth. Catal. 2020, 362, 2770–2777. [Google Scholar] [CrossRef]
  83. Halder, P.; Roya, T.; Das, P. Recent developments in selective N-arylation of azoles. Chem. Commun. 2021, 57, 5235–5249. [Google Scholar] [CrossRef]
  84. Neha, D.; Ashish, R.; Kumar, R.; Kumar, V. Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development. Curr. Org. Synth. 2018, 15, 321–340. [Google Scholar] [CrossRef]
  85. Ansari, A.; Ali, A.; Asif, M. Biologically active pyrazole derivatives. New J. Chem. 2017, 41, 16–41. [Google Scholar] [CrossRef]
  86. Gonda, Z.; Novák, Z. Transition-Metal-Free N-Arylation of Pyrazoles with Diaryliodonium Salts. Chem. Eur. J. 2015, 21, 16801–16806. [Google Scholar] [CrossRef] [PubMed]
  87. Bihari, T.; Babinszki, B.; Gonda, Z.; Kovács, S.; Novák, Z.; Stirling, A. Understanding and Exploitation of Neighboring Heteroatom Effect for the Mild N-Arylation of Heterocycles with Diaryliodonium Salts under Aqueous Conditions: A Theoretical and Experimental Mechanistic Study. J. Org. Chem. 2016, 81, 5417–5422. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Lu, N.; Huang, L.; Xie, L.; Cheng, J. Transition-Metal-Free Selective Iodoarylation of Pyrazoles via Heterocyclic Aryliodonium Ylides. Eur. J. Org. Chem. 2018, 2018, 3437–3443. [Google Scholar] [CrossRef]
  89. Riedmüllera, S.; Nachtsheim, B.J. Metal-Free N-Arylation of Indolines with Diaryliodonium Salts. Synlett 2015, 26, 651–655. [Google Scholar] [CrossRef]
  90. Purkait, N.; Kervefors, G.; Linde, E.; Olofsson, B. Regiospecific N-Arylation of Aliphatic Amines under Mild and Metal-Free Reaction Conditions. Angew. Chem. Int. Ed. 2018, 57, 11427–11431. [Google Scholar] [CrossRef]
  91. Mehra, M.K.; Tantak, M.P.; Arun, V.; Kumar, I.; Kumar, D. Metal-free regioselective formation of C–N and C–O bonds with the utilization of diaryliodonium salts in water: Facile synthesis of N-arylquinolones and aryloxyquinolines. Org. Biomol. Chem. 2017, 15, 4956–4961. [Google Scholar] [CrossRef]
  92. Dhiman, P.; Arora, N.; Veeraveedu, P.; Thanikachalam, P.V.; Monga, V. Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorg. Chem. 2019, 92, 103291–103335. [Google Scholar] [CrossRef]
  93. Li, X.-H.; Ye, A.-H.; Liang, C.; Mo, D.-L. Substituent Effects of 2-Pyridones on Selective O-Arylation with Diaryliodonium Salts: Synthesis of 2-Aryloxypyridines under Transition-Metal-Free Conditions. Synthesis 2018, 50, 1699–1710. [Google Scholar] [CrossRef] [Green Version]
  94. Kuriyama, M.; Hanazawa, N.; Abe, Y.; Katagiri, K.; Ono, S.; Yamamoto, K.; Onomura, O. N- and O-arylation of pyridin-2-ones with diaryliodonium salts: Base-dependent orthogonal selectivity under metal-free conditions. Chem. Sci. 2020, 11, 8295–8300. [Google Scholar] [CrossRef] [PubMed]
  95. Tinnis, F.; Stridfeldt, E.; Lundberg, H.; Adolfsson, H.; Olofsson, B. Metal-Free N-Arylation of Secondary Amides at Room Temperature. Org. Lett. 2015, 17, 2688–2691. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Xu, B.; Han, J.; Wang, L. Metal- and Base-Free Direct N-Arylation of Pyridazinones by Using Diaryliodonium Salts: An Anion Effect. Asian J. Org. Chem. 2018, 7, 1674–1680. [Google Scholar] [CrossRef]
Scheme 1. Metal-free C2-H arylation of five-membered heteroarenes using diaryliodonium salts.
Scheme 1. Metal-free C2-H arylation of five-membered heteroarenes using diaryliodonium salts.
Pharmaceuticals 14 00661 sch001
Scheme 2. C2-H arylation of tryptophane amino acids and peptide derivatives with diaryliodonium tosylates.
Scheme 2. C2-H arylation of tryptophane amino acids and peptide derivatives with diaryliodonium tosylates.
Pharmaceuticals 14 00661 sch002
Scheme 3. C2-H arylation of azaheteroanes using unsymmetrical aryl(TMB)iodonium triflates in the presence of NaOH.
Scheme 3. C2-H arylation of azaheteroanes using unsymmetrical aryl(TMB)iodonium triflates in the presence of NaOH.
Pharmaceuticals 14 00661 sch003
Scheme 4. Late-stage SF5-pyridinylation of pyrrole derivatives.
Scheme 4. Late-stage SF5-pyridinylation of pyrrole derivatives.
Pharmaceuticals 14 00661 sch004
Scheme 5. Base-mediated C-H arylation of α-free BODIPYs for the synthesis of α-arylBODIPY dyes.
Scheme 5. Base-mediated C-H arylation of α-free BODIPYs for the synthesis of α-arylBODIPY dyes.
Pharmaceuticals 14 00661 sch005
Scheme 6. Plausible radical mechanism for the regioselective synthesis of α-arylBODIPY.
Scheme 6. Plausible radical mechanism for the regioselective synthesis of α-arylBODIPY.
Pharmaceuticals 14 00661 sch006
Scheme 7. Direct late-stage C3-H arylation of various 2-arylimidazolo[1,2-a]pyridines using diphenyliodonium or di(p-tBu)phenyliodonium chlorides.
Scheme 7. Direct late-stage C3-H arylation of various 2-arylimidazolo[1,2-a]pyridines using diphenyliodonium or di(p-tBu)phenyliodonium chlorides.
Pharmaceuticals 14 00661 sch007
Scheme 8. Direct late-stage C3-H arylation of various 2-arylbenzo[d]imidazolo[2,1-b]thiazoles using diphenyliodonium chlorides.
Scheme 8. Direct late-stage C3-H arylation of various 2-arylbenzo[d]imidazolo[2,1-b]thiazoles using diphenyliodonium chlorides.
Pharmaceuticals 14 00661 sch008
Scheme 9. Direct late-stage C3-H arylation of quinoxalin-2(1H)-ones with diaryliodonium tetrafluoroborates.
Scheme 9. Direct late-stage C3-H arylation of quinoxalin-2(1H)-ones with diaryliodonium tetrafluoroborates.
Pharmaceuticals 14 00661 sch009
Scheme 10. Plausible radical pathway for the synthesis of 3-aryl-quinoxalin-2(1H)-ones.
Scheme 10. Plausible radical pathway for the synthesis of 3-aryl-quinoxalin-2(1H)-ones.
Pharmaceuticals 14 00661 sch010
Scheme 11. Visible-light-mediated late-stage C2-H arylation of diverse quinoline N-oxides using eosin Y as a photocatalyst.
Scheme 11. Visible-light-mediated late-stage C2-H arylation of diverse quinoline N-oxides using eosin Y as a photocatalyst.
Pharmaceuticals 14 00661 sch011
Scheme 12. Visible-light-mediated late-stage C2-H phenylation of diverse pyridine N-oxides using eosin Y as a photocatalyst and K2S2O8 as additive.
Scheme 12. Visible-light-mediated late-stage C2-H phenylation of diverse pyridine N-oxides using eosin Y as a photocatalyst and K2S2O8 as additive.
Pharmaceuticals 14 00661 sch012
Scheme 13. Suggested radical mechanism for the metal-free synthesis of 2-aryl quinoline and pyridine N-oxides.
Scheme 13. Suggested radical mechanism for the metal-free synthesis of 2-aryl quinoline and pyridine N-oxides.
Pharmaceuticals 14 00661 sch013
Scheme 14. Direct late-stage N-arylation of substituted pyrazoles with diaryliodonium salts.
Scheme 14. Direct late-stage N-arylation of substituted pyrazoles with diaryliodonium salts.
Pharmaceuticals 14 00661 sch014
Scheme 15. Direct N-heteroarylation of 3,5-diphenylpyrazole with unsymmetrical diaryliodonium triflates.
Scheme 15. Direct N-heteroarylation of 3,5-diphenylpyrazole with unsymmetrical diaryliodonium triflates.
Pharmaceuticals 14 00661 sch015
Scheme 16. Synthesis of N-mesitylpyrrolo[2,3-b]pyridines and -pyrimidine derivatives.
Scheme 16. Synthesis of N-mesitylpyrrolo[2,3-b]pyridines and -pyrimidine derivatives.
Pharmaceuticals 14 00661 sch016
Scheme 17. Synthesis of N-mesitylbenzo[d][1,2,3]triazole and 4-chloro-2-mesitylphthalazin-1(2H)-one.
Scheme 17. Synthesis of N-mesitylbenzo[d][1,2,3]triazole and 4-chloro-2-mesitylphthalazin-1(2H)-one.
Pharmaceuticals 14 00661 sch017
Scheme 18. Selective iodoarylation of pyrazole derivatives via the generation of the heteroayliodonium salt as key intermediate.
Scheme 18. Selective iodoarylation of pyrazole derivatives via the generation of the heteroayliodonium salt as key intermediate.
Pharmaceuticals 14 00661 sch018
Scheme 19. Selective tBuOK mediated N-arylation of indazole and triazole using diaryliodonium triflates as arylating reagents.
Scheme 19. Selective tBuOK mediated N-arylation of indazole and triazole using diaryliodonium triflates as arylating reagents.
Pharmaceuticals 14 00661 sch019
Scheme 20. Microwave-assisted metal-free N-arylation of quinolin-4(1H)one and 4-methylquinolin-2(1H)-one in water.
Scheme 20. Microwave-assisted metal-free N-arylation of quinolin-4(1H)one and 4-methylquinolin-2(1H)-one in water.
Pharmaceuticals 14 00661 sch020
Scheme 21. Scope of the heteroarenes for the microwave-assisted transition-metal-free N-arylation using diphenyliodonium triflate.
Scheme 21. Scope of the heteroarenes for the microwave-assisted transition-metal-free N-arylation using diphenyliodonium triflate.
Pharmaceuticals 14 00661 sch021
Scheme 22. Synthesis of N-arylated pyridinones as major products under optimized conditions.
Scheme 22. Synthesis of N-arylated pyridinones as major products under optimized conditions.
Pharmaceuticals 14 00661 sch022
Scheme 23. N-arylation of pyridin-2-ones under metal-free conditions.
Scheme 23. N-arylation of pyridin-2-ones under metal-free conditions.
Pharmaceuticals 14 00661 sch023
Scheme 24. Base-free and metal-free N-arylation of pyridazinones with diaryliodonium hexafluorophosphates.
Scheme 24. Base-free and metal-free N-arylation of pyridazinones with diaryliodonium hexafluorophosphates.
Pharmaceuticals 14 00661 sch024
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Besson, T.; Fruit, C. Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts. Pharmaceuticals 2021, 14, 661. https://doi.org/10.3390/ph14070661

AMA Style

Besson T, Fruit C. Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts. Pharmaceuticals. 2021; 14(7):661. https://doi.org/10.3390/ph14070661

Chicago/Turabian Style

Besson, Thierry, and Corinne Fruit. 2021. "Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts" Pharmaceuticals 14, no. 7: 661. https://doi.org/10.3390/ph14070661

APA Style

Besson, T., & Fruit, C. (2021). Recent Advances in Transition-Metal-Free Late-Stage C-H and N-H Arylation of Heteroarenes Using Diaryliodonium Salts. Pharmaceuticals, 14(7), 661. https://doi.org/10.3390/ph14070661

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop